The breakdown for semaglutide is especially alarming: out of 32 identified illegitimate shipments, only 2 were refused entry
The company's $4 billion manufacturing investment is designed to prevent this, but technical issues can still arise
References National Institute of Diabetes and Digestive and Kidney Diseases American Diabetes Association National Institutes of Health U.S
Emerging evidence highlights taste and olfactory disturbances as underrecognized NAEs of GLP-1 RA therapy 44,45,46
Retatrutide is investigated as a unimolecular agonist that engages three complementary incretin and glucagon pathways simultaneously, with research interest in body composition, hepatic lipid metabolism, glycemic endpoints, and energy expenditure in obesity and metabolic disease models
Bottom line Semaglutide is an injectable medication that helps control blood sugar and aids in weight management